Financial insights of CGTX

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Research and development	6,120	14,306*	3,773	11,481
General and administrative	2,697	2,964*	2,602	2,497
Total operating expenses	8,817	17,269	6,375	13,978
Loss from operations	-8,817	-17,269*	-6,375	-13,978
Grant income	3,979	10,921*	1,215	7,106
Other income, net	273	363*	230	141
Interest expense	-5	-4*	-	-3
Total other income, net	4,247	11,279*	1,445	7,244
Net loss	-	-5,991	-4,930	-6,734
Net loss and comprehensive loss	-4,570	-5,991	-4,930	-6,734

Basic EPS	-0.05	-0.078	-0.06	-0.11
Diluted EPS	-0.05	-0.078	-0.06	-0.11
Basic Average Shares	89,191,313	76,658,491	77,951,513	63,690,945
Diluted Average Shares	89,191,313	76,658,491	77,951,513	63,690,945

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.